Advertisement

Computational simulation of inhibitory effects of curcumin, retinoic acid and their conjugates on GSK-3 beta

  • Hemanshi Mishra
  • Rajesh Kumar KesharwaniEmail author
  • Dev Bukhsh Singh
  • Sandeep Tripathi
  • Shiv Kumar DubeyEmail author
  • Krishna Misra
Original Article
  • 52 Downloads

Abstract

Turmeric, since in ancient Indian traditional medicinal system, has been implicated for its therapeutic and chemopreventive properties against a broad spectrum of diseases. Curcumin, the active polyphenol from turmeric, helps to obstruct the growth of many types of cancers at various stages which include prostrate, melanoma, breast, brain tumor, pancreatic, leukemia, etc. The initiation and recurrence of cancer have been attributed to few mutated cells in bulk of tumor called as cancer stem cells which have the capacity of self-renewal and differentiation. Glycogen synthase kinase-3 beta (GSK-3B) is a multifunctional serine/threonine protein kinase, originally found in mammals, an important component of diverse signaling pathways, dysregulation of which leads to affect the cancer stem cell properties. The nutritional- and phytochemical-based dietary interventions may complement current chemotherapy to prevent recurrence and relapse of cancer. The objective of present study is to investigate the effect of retinoic acid and curcumin–retinoic acid conjugates against GSK-3B protein. The in silico results indicate that molecule 3 (curcumin–retinoic acid conjugates) might be a potent inhibitor of GSK-3B and a novel future drug candidate for the treatment of cancer.

Keywords

GSK-3B Curcumin Docking Cancer Computational Polyphenols 

Notes

Acknowledgements

One of the authors, Rajesh K. Kesharwani, is thankful to Prof. Krishna Misra, Honorary Professor, Indian Institute of Information Technology, Allahabad, for her kind suggestion for completion of the work.

Compliance with ethical standards

Conflict of interest

The authors report no conflict of interest.

References

  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242CrossRefGoogle Scholar
  2. Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114–131CrossRefGoogle Scholar
  3. Bharti AC, Donato N, Singh S, Aggarwal BB (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa B alpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101(3):1053–1062CrossRefGoogle Scholar
  4. CLC drug discovery work bench/Molegro Virtual Docker: CLC Inc A, Denmark. http://www.clcbio.com/products/clc-drug-discovery-workbench. Accessed 25 Jan 2016
  5. Davies H, Glodzik D, Morganella S, Yates LR, Staaf J, Zou X et al (2017) HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med 23(4):517CrossRefGoogle Scholar
  6. Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116(Pt 7):1175–1186CrossRefGoogle Scholar
  7. Gentile G, Merlo G, Pozzan A, Bernasconi G, Bax B, Bamborough P, Bridges A, Carter P, Neu M, Yao G, Brough C, Cutler G, Coffin A, Belyanskaya S (2012), 5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective Gsk-3 inhibitors. Bioorg Med Chem Lett 22:1989CrossRefGoogle Scholar
  8. Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65(4):391–426CrossRefGoogle Scholar
  9. Jauliac S, López-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4(7):540–544CrossRefGoogle Scholar
  10. Keservani RK, Kesharwani RK, Vyas N, Chadokar A (2010a) Nutritional supplements: an overview. Int J Curr Pharm Res 1(1):59–75Google Scholar
  11. Keservani RK, Kesharwani RK, Vyas N, Jain S, Raghuvanshi R, Sharma AK (2010b) Nutraceutical and functional food as future food: a review. Der Pharm Lett 2(1):106–116Google Scholar
  12. Kesharwani RK, Misra K (2011) Prediction of binding site for curcuminoids at human topoisomerase II α protein; an in silico approach. Curr Sci 101(8):1060–1064Google Scholar
  13. Kesharwani RK, Srivastava V, Singh P, Rizvi SI, Adeppa K, Misra K (2015) A novel approach for overcoming drug resistance in breast cancer chemotherapy by targeting new synthetic curcumin analogues against aldehyde dehydrogenase 1 (ALDH1A1) and glycogen synthase kinase-3 β (GSK-3β). Appl Biochem Biotechnol.  https://doi.org/10.1007/s12010-015-1696-x CrossRefGoogle Scholar
  14. Kesharwani RK, Singh DB, Singh DV, Misra K (2018) Computational study of curcumin analogues by targeting DNA topoisomerase II: a structure-based drug designing approach. Netw Model Anal Health Inform Bioinform 7:15.  https://doi.org/10.1007/s13721-018-0179-8 CrossRefGoogle Scholar
  15. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Prot Eng 8:127–134CrossRefGoogle Scholar
  16. Luo J (2008) Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy. Cancer Lett 273(2):194–200CrossRefGoogle Scholar
  17. Martinez GJ, Pereira RM, Äijö T, Kim EY, Marangoni F, Pipkin ME et al (2015) The transcription factor NFAT promotes exhaustion of activated CD8 + T cells. Immunity 42(2):265–278CrossRefGoogle Scholar
  18. Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15(1):28–33MathSciNetCrossRefGoogle Scholar
  19. Singh DB, Gupta MK, Kesharwani RK, Misra K (2013) Comparative docking and ADMET study of some curcumin derivatives and herbal congeners targeting b-amyloid. Netw Model Anal Health Inform Bioinform 2:13–27.  https://doi.org/10.1007/s13721-012-0021-7 CrossRefGoogle Scholar
  20. Singh DV, Agarwal S, Kesharwani RK, Misra K (2014) 3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: interaction with thioredoxin reductase. Interdiscip Sci 5(4):286–295CrossRefGoogle Scholar
  21. Upadhyaya J, Kesharwani RK, Misra K (2009) Metabolism, pharmacokinetics and bioavailability of ascorbic acid; synergistic effect with tocopherols and curcumin. J Comput Intell Bioinform 2(1):77–84Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Hemanshi Mishra
    • 1
  • Rajesh Kumar Kesharwani
    • 1
    Email author
  • Dev Bukhsh Singh
    • 2
  • Sandeep Tripathi
    • 2
  • Shiv Kumar Dubey
    • 3
    Email author
  • Krishna Misra
    • 4
  1. 1.Department of Advanced Science and TechnologyNIET, Nims University RajasthanJaipurIndia
  2. 2.Department of Biotechnology, Institute of Biosciences and BiotechnologyChhatrapati Shahu Ji Maharaj UniversityKanpurIndia
  3. 3.Department of Biochemistry, College of Basic Sciences and HumanitiesG.B. Pant University of Agriculture and TechnologyPantnagarIndia
  4. 4.Division of Applied Science and IRCBIndian Institute of Information TechnologyAllahabadIndia

Personalised recommendations